Copyright
©The Author(s) 2016.
World J Hepatol. Sep 18, 2016; 8(26): 1110-1115
Published online Sep 18, 2016. doi: 10.4254/wjh.v8.i26.1110
Published online Sep 18, 2016. doi: 10.4254/wjh.v8.i26.1110
WBC (3.3-8.6) | 6200/μL | Total protein (6.6-8.1) | 8.0 g/dL |
Hgb (13.7-16.8) | 15.0 g/dL | Albumin (4.1-5.1) | 4.7 g/dL |
Platelet (148-348) | 108 × 103 /μL | HBs antibody | (-) |
PT% (> 80) | 99% | HBc antigen | (-) |
INR | 0.92 | HCV antibody | (+) |
Total bilirubin (0.4-1.5) | 1.41 mg/dL | HCV-RNA | 6.4 logIU/mL |
Direct bilirubin (0.05-0.4) | 0.37 mg/dL | Alpha-fetoprotein (< 20) | 6.4 ng/mL |
Aspartate transaminase (13-30) | 36 IU/L | PIVKA-II (< 40) | 91 mAU/mL |
Alanine transaminase (10-42) | 35 IU/L | ICG (15 s) (< 15.0) | 14.0% |
- Citation: Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115
- URL: https://www.wjgnet.com/1948-5182/full/v8/i26/1110.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i26.1110